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Abstract
Objective—This study identified ways that consumers of mental health services are active
participants in psychiatric treatment.
Methods—Self-reported activity in treatment and observations of audio recorded psychiatric visits
were examined. Four providers (3 psychiatrists and one nurse practitioner) and 10 of their consumers
with severe mental illness (40 total) were recruited. Consumers completed questionnaires on patient
activation, illness self-management and medication attitudes on the day of a psychiatric visit. The
visit was audiotaped, transcribed, and thematically analyzed. Providers reported diagnosis, substance
abuse, and medication adherence.
Results—Self-reported patient activation was positively related to illness self-management and
negatively related to substance abuse. Consumers were active in partnership building, seeking and
displaying competence, and directing treatment; however, there was little relationship between self-
reported activation and observed behaviors.
Conclusions—Consumers are active in a variety of ways; but, similar to other populations, the
relationship to self-reported desire for involvement is not direct.
Living successfully with chronic health conditions requires active collaboration in managing
illness -- consumer and health care provider working together to identify problem areas, set
goals, learn self-management skills, and participate in follow-up (1). An active partnership is
critical because the majority of time spent managing chronic illnesses takes place when the
consumer is on his/her own in the community rather than in the provider’s office. Further,
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reviews have shown that positive, relationship-centered approaches translate into higher levels
of trust, satisfaction, reduced emotional burden, and improved biomedical markers such as
blood pressure and blood sugar control (2). Relationships in which patients are activated to
take greater control in treatment appear to be particularly important predictors of physical
health (3).
National policy supports an active role for consumers of mental health services, and research
indicates that people with severe mental illnesses such as schizophrenia want to take a role in
making decisions about their care (4). Shared decision-making is gaining more attention (5)
and interventions are being developed to improve activation and shared decision-making in
this population (6). Unfortunately, tools to assess active participation are lacking (5).
In the general medical field, the Patient Activation Measure (7) has been successfully used in
a variety of chronic health conditions including diabetes, arthritis, and high blood pressure.
The scale assesses an individual’s knowledge, skill, and confidence for actively managing
illness and has been associated with a variety of self-management behaviors including diet,
exercise, nutrition, self-monitoring, and reading about medications. Patient activation has also
been associated with service utilization, medication adherence, satisfaction with services, and
quality of life (8).
To better understand patient activation in people with severe mental illness, we conducted a
cross-sectional, mixed-methods, descriptive study assessing self-reported and observed patient
activation. We hypothesized that self-reported activation would be positively related to illness
self-management, positive attitudes towards medications, and provider-rated medication
adherence. We explored ways consumers were active during visits by identifying themes of
activation and rating each consumer’s overall activation. We hypothesized that observations
of activation would be related to self-reported activation, i.e., people who endorsed high levels
of activation on a questionnaire would be rated as more active in the visit.
Methods
The study took place between March and July, 2008 at a community mental health center in a
medium size Midwestern city serving children and adults with severe mental illnesses at 200%
of poverty level or below. The agency organizes treatment teams around the assertive
community treatment (ACT) model serving consumers who have a prior hospitalization
history, homelessness, and/or incarceration. We contacted prescribers who served adults, and
the first four we approached (of five possible) agreed to participate (three psychiatrists and one
nurse practitioner). A research assistant scheduled days to recruit 10 consumers per provider.
During recruitment, agency staff introduced the assistant who described the study and reviewed
the informed consent statement. Consumer participants completed a brief packet of surveys
prior to (or just after) the visit and were paid $10. Providers allowed us to audiotape the visit
and provided diagnosis and ratings of substance abuse and medication adherence; they were
not paid for their participation. All procedures were approved by IUPUI’s Institutional Review
Board.
We approached 43 consumers to gain a sample of 40 (a 93% participation rate). Two declined
citing lack of time, and one declined for personal reasons. Participants had a mean age of 43.5
±15.2 years, were predominantly Caucasian (31, 78%), and most had at least a high school
degree (28, 70%). About half were female (21, 53%). Diagnoses included schizophrenia/
schizoaffective disorder (25, 63%), bipolar disorder (4, 10%), major depression (8, 20%) or
other (3, 8%). Six (15%) had a co-occurring substance abuse disorder. Most were being served
on state-certified ACT teams (29, 73%).
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Activation was assessed with the short form, mental health version of the Patient Activation
Measure (7). The 13 items refer specifically to “mental health,” rather than “health” (e.g., “I
know what each of my prescribed mental health medications do”). Scores have a theoretical
range of 0 (least activation) to 100 (highest activation). Internal consistency was good
(Cronbach’s alpha = .83); scores ranged from 40.1 to 91.6, with a mean of 57.7 (SD=12.5).
See on-line appendix for sample distribution.
Illness self-management was assessed with the client version of the Illness Management and
Recovery Scale (9). The scale consists of 15 items rated on a 5-point behaviorally anchored
scale and include: progress toward goals, knowledge about mental illness, involvement with
significant others and self-help, time in structured roles, impairment in functioning, symptom
distress and coping, relapse prevention and hospitalizations, use of medications, and alcohol
and drug use. The scale has demonstrated adequate internal reliability, good test-retest
reliability, and convergent validity (9).
Medication attitudes were assessed with the 10-item Medication Adherence Rating Scale which
has been shown to have adequate internal consistency, test-retest reliability, and positive
correlations with related measures (10). This measure includes items such as “I take my
medication only when I am sick” and “My thoughts are clearer on medication.”
Provider ratings were given for medication adherence (1 = rarely/never, 2 = half the time, 3 =
usually, 4=always/almost always). Providers were asked the diagnosis for each consumer and
whether the individual had co-occurring substance abuse.
Observations of activation came from the 40 visits (one per consumer) that were audiotaped,
transcribed verbatim, reviewed for accuracy, de-identified, and imported into Atlas-ti. Through
an iterative, consensus-building process, we listened to and reviewed transcripts to identify
emergent themes related to activation. Initially four of us reviewed a transcript independently
to identify points where the consumer was active (or not active when expected) and what led
to this identification. We met as a group to discuss our findings and repeated this process on
several transcripts until we had a set of defined codes. Then three of us coded transcripts in
blocks of three (two independently and the third in common) to maintain inter-rater reliability.
We met weekly to compare coding of the common transcripts, resolve discrepancies and refine
coding through consensus. We also rated each transcript on the extent to which the consumer
1) was active in the negotiation about treatment, 2) seemed interested in the management of
his/her mental illness, and 3) was involved in controlling his/her mental illness, based on
research in diabetes management (11). However, we used a cruder rating scale (0 = not at all;
1 = a little; 2 = somewhat; 3 = a lot) because we did not have the history of prior data for more
fine-grained levels of activation.
We examined Pearson correlations among all measures, and categorical variables (e.g.,
substance abuse) were dummy-coded as 0 or 1 to indicate presence or absence of the variable.
We used correlations to test the hypotheses that self-reported activation would be related to
self-management and medication adherence, and to examine whether self and provider ratings
would predict coder ratings of activation. Thematic analysis identified ways in which
consumers were active.
Results
Background characteristics (age, gender, race, education and diagnosis of schizophrenia) were
unrelated to self-reported activation, illness self-management, medication attitudes or
medication adherence. As shown in Table 1, self-reported patient activation was related to
higher levels of illness self-management (r = .46, p < .01) and less substance abuse according
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to provider report (−.35, p < .01). However, activation was not significantly related to
medication attitudes or provider ratings of medication adherence.
The mean length of visit was 19.0 ± 6.0 minutes (ranging from 9.0 to 32.2). Length of visit
was not significantly related to activation, illness self-management, medication attitudes,
prescriber ratings, or coder ratings of activation. Coder ratings of active involvement based on
the transcripts were not significantly related to self-reported activation, illness self-
management, medication attitudes or medication adherence (Table 2).
Thematic analyses revealed four broad types of consumer activation: partnership building,
seeking and displaying competence, directing treatment, and missed opportunities.
Partnership Building included praise opportunities, activity outside the visit, and self-
disclosure. Praise opportunities occurred when consumers called attention to positive affect or
efforts, often placing themselves in a positive light along the path to recovery, e.g., “And my
math is getting better…I’m working on it every day.” Activity outside the session involved
consumer reports at improving mental health (e.g., adhering to a medication regimen) or
broader life improvement, e.g., “I’m going back through the job training program. I have a
meeting on that today.” Self-disclosure involved revealing new information containing a moral
or affective component, at times prompted by the provider (e.g., asking if a consumer was
taking illicit drugs), and at other times unsolicited: “I have a lot of anger toward people, a
lot….To be honest with you, it is very, very embarrassing.”
Seeking/Displaying Competence was evident when consumers asked questions, often related
to medication dosage, side effects, and new or unusual symptoms. Consumers frequently
displayed understanding of illness (e.g., when symptoms are better or worse) and treatment
(e.g., knowing timing and dosage), or deeper understanding, e.g., recognizing consequences
of behaviors such as substance abuse, exercise, and taking medication as prescribed. Another
degree of competence emerged when consumers took responsibility for their behaviors: “I’m
a responsible adult…I can’t be acting like a teenager.”
Directing Treatment varied from more passive strategies, such as voicing a concern, to
expressing opinions about treatment, to specific requests of the provider. Expressions of
concern included mental health symptoms, medication side effects, physical symptoms, and
general life concerns e.g., job stresses, worries about obtaining a high school diploma, and
saving for retirement. Consumers offered evaluations of how the treatment was working (or
not) and sometimes discussed how they felt about the treatment, e.g., “I still don’t like the way
it makes me so tired at night. Cause after I take ‘em I can’t go out…I slur my speech.” At the
most active end of the spectrum were direct requests. A few consumers asked for a particular
medication, a change in dosage or timing, or specifically that no changes be made. For one
consumer, medication was interfering with her work “I… I think…is there any way you could
start me out right now on a lower dose to get me adjusted because it pretty much leaves me
comatose, really.”
Missed Opportunities, the final theme, referred to missed opportunities on the consumer’s part
to become more involved in treatment. Usually this occurred when the consumer responded
minimally to provider questions, only to bring up concerns later. In one case the provider was
trying to engage the consumer in a conversation about goals, but the consumer responded
“Uh…my goals…I don’t remember.” (To be fair, this provider had also forgotten: “Well, I
can’t remember exactly what they were, but I bet you’re a lot closer to them now than what
you were a year ago.”)
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Discussion
This is the first study we are aware of that explores the role of patient activation in people with
severe mental illnesses. The Patient Activation Measure had good internal consistency and
correlated with self-management and substance abuse in meaningful ways. Consumers high in
activation rated themselves higher in illness self-management and recovery, and were less
likely to be identified by the provider as having a substance abuse problem. Activation was
not significantly related to medication attitudes or adherence. However, correlations were in
the expected direction and the small sample size restricted our ability to detect anything other
than moderate to large effects. Further validation is needed, but this initial examination appears
promising for use with people with severe mental illnesses.
Activation was not related to coder ratings in terms of negotiation, interest in managing the
illness, and involvement in controlling the illness. Even considering the small sample size, the
magnitude of the relationships was very small. The lack of relationship may reflect a general
lack of concordance between attitudes and behaviors; what people think and how they actually
behave are different things. Other studies of healthcare communication have found that patient
ratings of involvement have not correlated with actual behaviors (12). Similarly, doctors often
overestimate their own behaviors, such as the amount of time spent in giving information during
encounters (13). Additionally, we may have observed visits in which highly activated
consumers simply did not have issues to bring up at that particular visit and, therefore, did not
appear active. Of course, it is also possible that our coding scheme was not sensitive or was
tapping into the wrong areas.
Thematic analysis of the transcripts revealed numerous behaviors reflecting consumer
activation. Some of these behaviors were expected, such as asking questions or displaying
knowledge, common indicators of patient activation in other chronic illnesses (14). Basic
knowledge about the medical condition and its treatment are fundamental to being an active
participant. By contrast, direct requests, perhaps the most active form of behavior, were evident
in only a few transcripts. Consumers were generally more indirect or passive, offering opinions
and more frequently statements of concern. In the absence of specific coaching for consumers,
providers may need to be primed to look for ways in which consumers ask for help. Also,
because in-session behavior may not accurately indicate consumer preferences for
involvement, providers may need to have more focused discussions about preferences and
decision-making.
Another interesting set of behaviors involved partnership building, in which consumers talked
about how they were active outside the session, provided opportunities for praise, and disclosed
personal or sensitive information. This latter behavior, in particular, may indicate the
consumer’s trust in his or her provider, which in turn may help facilitate the two parties working
together to make decisions that are most beneficial to the consumer. These attributes are
fundamental to the concept of relationship-centered care and the role of reciprocal influence
in the provider-consumer relationship (15).
This study was based on a small non-representative sample from one agency and may not be
generalizable to the population of individuals with severe mental illnesses. Additionally,
because this study was cross-sectional, with one visit per consumer observed, it provides only
a window into the consumer’s overall experience. We were not able to assess the development
of relationships over time, nor did we gather information on how long the two parties had been
working together or other aspects of the consumer-provider relationship that may influence
communication. Despite these limitations, this study provides a more complete picture of
patient activation by measuring this construct quantitatively while simultaneously looking for
manifestations of activation in actual consumer-provider interactions. Furthermore, while
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healthcare communication research tends to focus on the provider role in interactions, this
study provides a view of the interaction and activation from the consumer’s perspective. Future
analyses will focus on the interactions of both consumer and provider, essential in fully
understanding shared decision-making processes. Future research should also examine the
relationship between activation and meaningful clinical outcomes, for example, reduced
relapses or improved work or other functional indicators. Finally, it would also be interesting
to examine the relationship between patient activation and the much broader concept of
consumer empowerment, the former being a potentially important component of the latter.
Conclusions
Patient activation is an important construct in collaborative care for chronic illnesses. Although
further validation is needed, the patient activation measure appears promising for use in
consumers with severe mental illnesses. In addition, activation may take different forms, with
consumers displaying a range of behaviors that are related to being an informed, active
collaborator in the recovery process.
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Table 2
Correlations between self and prescriber report and observer ratings of activation
Variables
Active in
Negotiation
Interest in
Mental
Illness
Management
Involved in
Controlling
Mental Illness
Patient Activation Measure .07 −.01 .08
Illness Self-Management .14 .11 .27
Medication Attitudes −.08 .08 .20
Prescriber Rated Medication Adherence −.16 −.11 −.05
Prescriber Rated Substance Abuse .15 .27 .17
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